Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Lambert

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
British Journal of Anaesthesia|January 8, 2025
Targeting the kappa opioid receptor for analgesia and antitumour effectsDavid G Lambert, Joshua S Mincer
Expert Opinion on Drug Discovery|November 24, 2021
Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative painAmmar A H Azzam, David G Lambert
Journal of Anesthesia|August 8, 2007
Role of urotensin II and its receptor in health and diseaseJohn McDonald, Madura Batuwangala, David G Lambert
Anesthesia and Analgesia|November 29, 2002
Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cellsKazuyoshi Hirota, Yoshio Hashimoto, David G Lambert
Journal of Anesthesia|July 29, 2018
Opioids, gliosis and central immunomodulationSalim Kadhim, John McDonald, David G Lambert
Anesthesia and Analgesia|May 23, 2003
The effects of local and intravenous anesthetics on recombinant rat VR1 vanilloid receptorsKazuyoshi Hirota, Darren Smart, David G Lambert
Handbook of Experimental Pharmacology|February 17, 2019
N/OFQ-NOP System in Peripheral and Central ImmunomodulationSalim Kadhim, Mark F Bird, David G Lambert
BJA Open|August 17, 2023
Opioids and cancer survival: are we looking in the wrong place?Despina Giakomidi, Mark F Bird, David G Lambert
British Journal of Anaesthesia|April 24, 2019
Hot topics in opioid pharmacology: mixed and biased opioidsAmmar A H Azzam, John McDonald, David G Lambert
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 9, 2012
In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligandsBenjamin D Hunt, Leong L Ng, David G Lambert
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
British Journal of Anaesthesia|January 8, 2025
Targeting the kappa opioid receptor for analgesia and antitumour effectsDavid G Lambert, Joshua S Mincer
Expert Opinion on Drug Discovery|November 24, 2021
Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative painAmmar A H Azzam, David G Lambert
Journal of Anesthesia|August 8, 2007
Role of urotensin II and its receptor in health and diseaseJohn McDonald, Madura Batuwangala, David G Lambert
Anesthesia and Analgesia|November 29, 2002
Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cellsKazuyoshi Hirota, Yoshio Hashimoto, David G Lambert
Journal of Anesthesia|July 29, 2018
Opioids, gliosis and central immunomodulationSalim Kadhim, John McDonald, David G Lambert
Anesthesia and Analgesia|May 23, 2003
The effects of local and intravenous anesthetics on recombinant rat VR1 vanilloid receptorsKazuyoshi Hirota, Darren Smart, David G Lambert
Handbook of Experimental Pharmacology|February 17, 2019
N/OFQ-NOP System in Peripheral and Central ImmunomodulationSalim Kadhim, Mark F Bird, David G Lambert
BJA Open|August 17, 2023
Opioids and cancer survival: are we looking in the wrong place?Despina Giakomidi, Mark F Bird, David G Lambert
British Journal of Anaesthesia|April 24, 2019
Hot topics in opioid pharmacology: mixed and biased opioidsAmmar A H Azzam, John McDonald, David G Lambert
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 9, 2012
In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligandsBenjamin D Hunt, Leong L Ng, David G Lambert
Pageof 10